These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7050471)

  • 1. [Systemic effects of topically applied hydrocortisone 17-butyrate 21-propionate ointment--comparative studies with betamethasone 17-valerate and hydrocortisone 17-butyrate ointment (author's transl)].
    Takeda K
    Nihon Hifuka Gakkai Zasshi; 1982 Mar; 92(4):503-13. PubMed ID: 7050471
    [No Abstract]   [Full Text] [Related]  

  • 2. [Systemic effects of topically applied clobetasone 17-butyrate ointment--comparative studies with hydrocortisone 17-butyrate ointment (author's transl)].
    Nihon Hifuka Gakkai Zasshi; 1980; 90(6):491-502. PubMed ID: 6967986
    [No Abstract]   [Full Text] [Related]  

  • 3. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
    Serup J; Holm P
    Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative double-blind study of a 0.1% hydrocortisone-17-butyrate cream (Locoid) and a 0.1% betamethasone-17-valerate cream (Betnovate) in patients with noninfected eczema].
    von Fischer F
    Ther Umsch; 1984 Jun; 41(6):429-32. PubMed ID: 6379975
    [No Abstract]   [Full Text] [Related]  

  • 5. [Systemic effects of topical application of beclomethasone dipropionate--comparative studies with betamethasone 17-valerate ointment and fluocinonide cream (author's transl)].
    Nihon Hifuka Gakkai Zasshi; 1979 Feb; 89(2):61-8. PubMed ID: 374799
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hydrocortisone butyrate (Locoid) compared with betamethasone valerate. A controlled clinical trail].
    Thormann J
    Ugeskr Laeger; 1976 Jan; 138(4):214-6. PubMed ID: 766347
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind comparison of quarter strength clobetasol propionate in Unguentum Merck with betamethasone valerate in psoriasis.
    Stankler L
    Br J Clin Pract; 1983; 37(11-12):389-91. PubMed ID: 6367795
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of psoriasis with 0.1% domoprednate (a D-homocorticosteroid) and 0.1% betamethasone valerate ointment. A double-blind, randomized trial.
    Christiansen JV; Foged E; Holm P; Jørgensen AS; Reymann F
    Dermatologica; 1985; 170(4):195-8. PubMed ID: 3888709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical corticosteroids in seborrhoeic dermatitis. A report from The General Practitioner Research Group.
    Practitioner; 1982 Jun; 226(1368):1178-9. PubMed ID: 6213951
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative efficacy of hydrocortisone valerate 0.2 percent ointment in the treatment of atopic dermatitis.
    Sefton J; Kyriakopoulos AA
    Cutis; 1983 Jul; 32(1):89-91, 94. PubMed ID: 6349943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of eczematous dermatitis with amcinonide or betamethasone valerate. A double-blind comparative study.
    Rosenberg EW
    Cutis; 1979 Dec; 24(6):642-5. PubMed ID: 391500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of hydrocortisone valerate 0.2% ointment.
    Sefton J; Loder JS; Kyriakopoulos AA
    Clin Ther; 1984; 6(3):282-93. PubMed ID: 6373007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical use of caffeine with hydrocortisone in the treatment of atopic dermatitis.
    Kaplan RJ; Daman L; Rosenberg EW; Feigenbaum S
    Arch Dermatol; 1978 Jan; 114(1):60-2. PubMed ID: 339846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of systemic adverse effects after prolonged local therapy with betamethasone-17-valerate ointment].
    Halsos AM
    Tidsskr Nor Laegeforen; 1978 Feb; 98(4):199-200. PubMed ID: 625746
    [No Abstract]   [Full Text] [Related]  

  • 15. A test of the half-side comparative design in the clinical evaluation of topical steroids, using diflucortolone and betamethasone creams.
    August PJ; Platt NE; Wiseman RA
    Br J Clin Pract; 1985 Oct; 39(10):383-7. PubMed ID: 3907679
    [No Abstract]   [Full Text] [Related]  

  • 16. Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
    Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
    Dermatologica; 1982 Sep; 165(3):204-7. PubMed ID: 6751889
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
    Gomez EC; Kaminester L; Frost P
    Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial comparing hydrocortisone 17-butyrate to betamethasone 17-valerate in a series of patients with eczematous skin diseases.
    Thormann J; Brodthagen H
    Dermatologica; 1976; 152 Suppl 1():209-14. PubMed ID: 782955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].
    van der Harst LC; Smeenk G; Burger PM; van der Rhee HJ; Polano MK
    Ned Tijdschr Geneeskd; 1978 Feb; 122(7):219-23. PubMed ID: 345134
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of psoriasis: comparative study using allantoin coal tar extract combined with hydrocortisone and betamethasone valerate.
    Almeyda J; Wood H
    Br J Clin Pract; 1979 Apr; 33(4):106-8. PubMed ID: 475951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.